INTEGRATION OF CHEMOTHERAPY INTO A COMBINED MODALITY APPROACH FOR CANCER TREATMENT .4. PANCREATIC ADENOCARCINOMA

被引：123

作者：

CARTER, SK

COMIS, RL

机构：

[1] NCI,DIV CANC TREATMENT,BETHESDA,MD 20014

[2] UPSTATE MED CTR,SYRACUSE,NY

来源：

关键词：

D O I：

10.1016/S0305-7372(75)80003-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：193 / 214

页数：22

共 129 条

[21]

COSTANZI JJ, 1969, CANCER, V23, P589, DOI 10.1002/1097-0142(196903)23:3<589::AID-CNCR2820230310>3.0.CO

[22]

2-A

[23]

CRAIGHEAD CC, 1958, ANN SURG, V147, P931

[24]

CRESSY NL, 1966, CANCER CHEMOTH REP, P683

[25]

CRILE G, 1970, SURG GYNECOL OBSTETR, V130, P1049

[26]

CURRERI AR, 1958, CANCER RES, V18, P478

[27]

DOLL R, 1966, CANCER INCIDENCE 5 C

[28]

EVANS RW, 1966, HISTOLOGICAL APPEARA, P1063

[29]

FEDUSKA NJ, 1971, ARCH SURG-CHICAGO, V103, P330

[30]

FIELD J, 1963, CANCER CHEMOTH REP, V33, P45